PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-3226

  1. 118 Posts.
    lightbulb Created with Sketch. 10
    Just wondering why you only posted what appears tobe a covring letter describing the last momet extension. Posy the whole document.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.